Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Prevention Programme for Improvement of Well-being and Level of Participation in Adolescents With Enhanced Psychiatric Burden in the School Environment.

Study ID: NCT06390384
Start Date: 2026-08-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

blinded-care counselling

App STEPS

digital and mental literacy training

Sponsor

RWTH Aachen University

Source: clinicaltrials.gov

Share:
Add to list

The PredictPlusPrevent Study

Study ID: NCT06351800
Start Date: 2026-02-15
End Date: 2028-03-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

9000

Intervention / Treatment

Predictplusprevent intervention

Psychoeducational intervention

Sponsor

The Mediterranean Institute for the Advance of Biotechnology and Health Research

Source: clinicaltrials.gov

Share:
Add to list

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Study ID: NCT07089992
Start Date: 2025-11-11
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

Pembrolizumab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma

Study ID: NCT07183852
Start Date: 2026-03
End Date: 2033-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Autologous Tumor Infiltrating Lymphocytes (TIL)

Melphalan

Interleukin-2

Sponsor

Clothing Gotland Region

Source: clinicaltrials.gov

Share:
Add to list

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Study ID: NCT07196033
Start Date: 2026-01
End Date: 2028-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment
Sponsor

Tata Memorial Hospital

Source: clinicaltrials.gov

Share:
Add to list

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Study ID: NCT07218315
Start Date: 2026-04-30
End Date: 2031-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

CellFX nsPFA Percutaneous Electrode System

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.

Study ID: NCT06379685
Start Date: 2025-12-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

PRO-190

Systane Ultra®

Sponsor

Sophia Laboratories S.A de C.V.

Source: clinicaltrials.gov

Share:
Add to list

Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections

Study ID: NCT07224997
Start Date: 2025-12-01
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Drug: Trimethoprim-Sulfamethoxazole (TMP/SMX) 160/800 mg tablets every 48 hours

Placebo

Sponsor

Guadalajara Civil Hospital

Source: clinicaltrials.gov

Share:
Add to list

Early Intervention After Traumatic Exposure in Children and Adolescents

Study ID: NCT07207018
Start Date: 2025-12
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

CFTSI (Child and Family Traumatic Stress Intervention)

non-specific psychological support therapy

Sponsor

University Hospital, Montpellier

Source: clinicaltrials.gov

Share:
Add to list

Robson Ten-Group Classification Study of Cesarean Section Rates in Assiut Hospitals

Study ID: NCT07194876
Start Date: 2025-12-01
End Date: 2027-02-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

770

Intervention / Treatment

No Intervention (subjects were previously treated with Onglyza®)

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list